In 2015, the world adopted 17 sustainable development goals (SDGs) with 169 targets to be achieved by 2030. […]
Category: COVID-19
AbstractObjectiveTo describe the development and validation of a novel patient reported outcome measure for symptom burden from long […]
The government’s Antivirals Taskforce has procured more antivirals per population than any other country in Europe, with over […]
The data on which the approval of molnupiravir was based in Japan1 and the data reported by Bernal […]
Brophy’s editorial on Merck’s Move-Out trial of molnupiravir raises important concerns about the approval of molnupiravir to treat […]
Using a different covid-19 vaccine for the third “booster” dose than was used for the initial two doses […]
The NHS has relaxed infection prevention and control (IPC) requirements for hospitals and GP practices that were introduced […]
Covid-19 cases in the US rose by 43% over the past two weeks, with especially high rates seen […]
The prevalence of sexually transmitted diseases (STDs) and deaths from drug overdoses increased in the US over the […]